Thyroid cancer in older men

References

• Yancick R, Ries LA. Cancer in older persons. Cancer 1994;74:1995–2003.
   Google Scholar
• Audisio RA, Repetta L, Zagonel V. Cancer in the elderly. In: UICC manual of clinical oncology. Pollock RE, Doroshow JH, editors. 8th ed. New Jersey: Wiley-Liss, 2004: (39):849–873.
   Google Scholar
• Chen AY, Jemal A, Ward EM. Increasing incidence of differentiated thyroid cancer in the United States, 1988–2005. Cancer 2009;115:3801–3807.
   PubMed Web of Science ®Google Scholar
• Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973–2002. JAMA 2006;295:2164–2167.
   PubMed Web of Science ®Google Scholar
• Monganti S, Ceda GP, Saccani M, et al. Thyroid disease in the elderly: Sex-related differences in clinical expression. J Endocrinol Invest 2005;28(11 Suppl Proceedings):101–104.
   Google Scholar
• Mazzaferri E. Management of a solitary thyroid nodule. NEJM 1993;328:553–559.
   PubMed Web of Science ®Google Scholar
• Schlumberger MJ, Filetti S, Hay ID. Nontoxic diffuse and nodular goiter and thyroid neoplasia. 11th ed. Kronenberg: Williams Textbook of Endocrinology; 2008. Chapter 13.
   Google Scholar
• Frates MCFr, Benson CB, Charboneau JW, Cibas ES, Clark OH, Coleman BG, Cronan JJ, Doubilet PM, Evans DB, Goellner GR, et al. Management of thyroid nodules detected at US: Society of Radiologists in Ultrasound consensus conference statement. Radiology 2005;237:794–800.
   PubMed Web of Science ®Google Scholar
• Papini E, Guglielmi R, Bianchini A, Crescenzi A, Toccogna S, Nardi F, Panunzi C, Rinaldi R, Toscano V, Pacella C. Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and color-Doppler features. J Clin Endocrinol Metab 2002; 87:1941–1946.
   PubMed Web of Science ®Google Scholar
• Lin JD, Chao TC, Huang BY, Chen ST, Chang HY, Hsueh C. Thyroid cancer in the thyroid nodules evaluated by ultrasonagraphy and fine-needle aspiration cytology. Thyroid 2005;15:708–717.
   PubMedGoogle Scholar
• Belfiore A, La Rosa GL, La Porta GA, et al. Cancer risk in patients with cold thyroid nodules: relevance of iodine intake, sex, age, and multinodularity. Am J Med 1992;93:363–369.
   PubMed Web of Science ®Google Scholar
• Blum M, Rothschild M. Improved nonoperative diagnosis of the solitary “cold” thyroid nodule: surgical selection based on risk factors and three months of suppression. JAMA 1980; 243:242–245.
   PubMed Web of Science ®Google Scholar
• Welker MJ, Orlov D. Thyroid nodules. Am Fam Physician 2003;67:559–566.
   Google Scholar
• Lin JD, Chao TC, Chen ST, Weng HF, Lin KD. Characteristics of thyroid carcinomas in aging patients. Eur J Clin Invest 2000;30:147–153.
   Google Scholar
• Tuttle M, Leboeuf R, Martorella A. Papillary thyroid cancer: monitoring and therapy. Endocrinol Metab Clin 2007;36: 753–778.
   Google Scholar
• Kilfoy BA, Devesa SS, Ward MH, Zhang Y, Rosenberg PS, Holford TR, Anderson WF. Gender is an age-specific effect modifier for papillary cancers of the thyroid gland. Cancer Epidemiol Biomarkers Prev 2009;4: 1092–1100.
   Google Scholar
• Arturi F, Russo D, Giuffrida D, Ippolito A, Perrotti N, Vigneri R , Filetti S. Early diagnosis by genetic analysis of differentiated thyroid cancer metastases in small lymph nodes. J Clin Endocrinol Metab 1997;82:1638–1641.
   Google Scholar
• Qubain S.W, Nakano S, Baba M, Takao S, Aikou T. Distribution of lymph node micrometastasis in pN0 well-differentiated thyroid carcinoma. Surgery 2002;131:249–256.
   PubMed Web of Science ®Google Scholar
• McConahey WM, Hay ID, Woolner LB, van Heerden JA, Taylor WF. Papillary thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy, and outcome. Mayo Clin Proc 1986;61:978–996.
   PubMed Web of Science ®Google Scholar
• Sebastian SO, Gonzalez JM, Paricio SP, Perez S, Flores P, Madrona P, Romero RP, Tebar FJ. Papillary thyroid carcinoma: prognostic index for survival including the histological variety. Arch Surg 2000;135:272–277.
   PubMed Web of Science ®Google Scholar
• Mazaferri EL. Papillary thyroid carcinoma: factors influencing prognosis and current therapy. Semin Oncol 1987;14;315–332.
   Google Scholar
• Goldballe C, Asschenfeld P, Sorensen JA, Sorensen MW, Jorgensen K. Papillary thyroid carcinoma: correlations between prognosis, age, and clinicopathological and histomorphological findings. Laryngoscope 1994;104: 747–751.
   Google Scholar
• Sautter-Bihl M, Raub J, Hetzel-Sesterheim M, Heinze HG. Differentiated thyroid cancer. Prognostic factors and influence of treatment on the outcome in 441 patients. Strahlenther Onkol 2001;177:125–131.
   Google Scholar
• Hawk WA, Hazzard JB. The many appearances of papillary carcinoma of the thyroid. Clev Clin Q 1976;43:207–216.
   PubMedGoogle Scholar
• Machens A, Hauptmann S, Dralle H. Disparities between male and female patients with thyroid cancers: sex difference or gender divide? Clin Endocrinol 2006;65:500–505.
   PubMed Web of Science ®Google Scholar
• Levi F, Randimbison L, Te VC, La Vecchia C. Thyroid cancer in Vaud, Switzerland: an update. Thyroid 2002;12:163–167.
   Google Scholar
• Mazzaferri E, Lhiang S. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 1994;97:418–428.
   PubMed Web of Science ®Google Scholar
• Correra P, Chen VW. Endocrine gland cancer. Cancer 1995;75(Suppl):338–352.
   Google Scholar
• Gupta KL. Neoplasm of the thyroid gland. Clin Geriatr Med 1995;11:271–290.
   Google Scholar
• Grebe SKG, Hay ID. Follicular thyroid cancer. Endocrinol Metab Clin North Am 1996;24:761–801.
   Google Scholar
• Phitayakorn R, Mchenry C. Follicular and Hurthle cell carcinoma of the thyroid gland. Surg Oncol Clin N Am 2006;15:603–623.
   Google Scholar
• Woolner LB. Thyroid carcinoma: pathologic classification with data on prognosis. Semin Nucl Med 1971;1:481–502.
   PubMedGoogle Scholar
• Schneider AB, Sarne DH. Long-term risks for thyroid cancer and other neoplasms after exposure to radiation. Natl Clin Pract Endocrinol Metab 2005;1:82.
   Google Scholar
• Mazzaferri E. Thyroid Cancer. Principles and practice of endocrinology and metabolism. 3rd ed, 2001. Chapter 40, Lippincott Williams and Wilkins, Philadelphia.
   Google Scholar
• Tuttle M, Lemar H, Burch H. Clinical features associated with an increased risk of thyroid malignancy in patients with follicular neoplasia by fine-needle aspiration. Thyroid 1998;8: 377–383.
   PubMed Web of Science ®Google Scholar
• Crile G, Pontius KI, Hawk WA. Factors influencing the survival of patients with follicular carcinoma of the thyroid gland. Surg Gynecol Obstet 1985;160:409–413.
   Google Scholar
• Brandi ML, Gagel RF, Angeli A, Bilezikean JP, Beck-Peccoz P, Bordi C, Conte-Devolx B, Falchetti A, Gheri RG, Libroia A, et al. Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 2001;86:5658–5671.
   PubMed Web of Science ®Google Scholar
• Kebebew E, Ituarte PH, Siperstein AE, Duh QY, Clark OH. Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems. Cancer 2000;88:1139–1148.
   PubMed Web of Science ®Google Scholar
• Sherman Steven. Thyroid carcinoma. Lancet 2003;361:501–511.
   PubMed Web of Science ®Google Scholar
• Elisei R, Bottici V, Luchetti F, Coscio G, Romei C, Grasso L, Miccoli P, Iaconni P, Basolo F, Pinchera A. Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders. J Clin Endocrinol Metab 2004;89:163–168.
   PubMed Web of Science ®Google Scholar
• Hahm JR, Lee MS, Min YK, Lee MK, Kim KW, Nam SJ, Yang JH, Chung JH. Routine measurement of serum calcitonin is useful for early detection of medullary thyroid carcinoma in patients with nodular thyroid diseases. Thyroid 2001;11:73–80.
   PubMed Web of Science ®Google Scholar
• Redding AH, Levine SN, Fowler MR. Normal preoperative calcitonin levels do not always exclude medullary thyroid carcinoma in patients with large palpable thyroid masses. Thyroid 2000;10:919–922.
   PubMed Web of Science ®Google Scholar
• Saad MF, Ordonez NG, Rashid RK, Guido JJ, Hill SC, Hickey RC, Samaan NA. Medullary carcinoma of the thyroid. Medicine 1984;63:319–342.
   PubMed Web of Science ®Google Scholar
• Scopsi L, Sampietro G, Boracchi P, Del Bo R, Gullo M, Placucci M, Pilotti S. Multivariate analysis of prognostic factors in sporadic medullary carcinoma of the thyroid. A retrospective study of 109 consecutive patients. Cancer 1996;78:2173–2183.
   PubMed Web of Science ®Google Scholar
• Hundahl SA, Fleming ID, Fremgen AM, Menck HR. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the US, 1985–1995. Cancer 1998;83:2638–2648.
   PubMed Web of Science ®Google Scholar
• Are C, Shaha AR. Anaplastic thyroid carcinoma: biology, pathogenesis, prognostic factors, and treatment approaches. Ann Surg Oncol 2006;13:453–464.
   PubMed Web of Science ®Google Scholar
• Hadar T, Mor C, Shvero J, Levy R, Segal K. Anaplastic carcinoma of the thyroid. Eur J Surg Oncol 1993;19:511–516.
   Google Scholar
• Gilliland FD, Hunt WC, Morris DM, Key CR. Prognostic factors for thyroid carcinoma: a population-based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) program 1973–1991. Cancer 1997;79:564–573.
   PubMed Web of Science ®Google Scholar
• Ain KB. Anaplastic thyroid carcinoma: a therapeutic challenge. Semin Surg Oncol 1999;16:64–69.
   PubMed Web of Science ®Google Scholar
• Giuffrida D, Gharib H. Anaplastic thyroid carcinoma: current diagnosis and treatment. Ann Oncol 2000;11:1083–1089.
   PubMed Web of Science ®Google Scholar
• Haigh PI, Ituarte PH, Wu HS, Treseler PA, Posner MD, Quivey JM, Duh QY, Clark OH. Completely resected anaplastic thyroid carcinoma combined with adjuvant chemotherapy and irradiation is associated with prolonged survival. Cancer 2001;91:2335–2342.
   PubMed Web of Science ®Google Scholar
• Kim TY, Kim KW, Jung TS, Kim JM, Kim SW, Chung K, Kim EY, Gong G, OH YL, Cho SY, et al. Prognostic factors for Korean patients with anaplastic thyroid carcinoma. Head Neck 2007;29:765–772.
   Google Scholar
• Pierie JP, Muzikansky A, Gaz RD, Faquin WC, Ott MJ. The effect of surgery and radiotherapy on outcome of anaplastic thyroid carcinoma. Ann Surg Oncol 2002;9:57–64.
   Google Scholar
• Kebebew E, Greenspan FS, Clark OH, Woeber KA, McMillan A. Anaplastic thyroid carcinoma treatment outcome and prognostic factors. Cancer 2005;103:1330–1335.
   PubMed Web of Science ®Google Scholar
• Tan RK, Finley RK, Driscoll D, Bakamjian V, Hicks WL, Shedd DP. Anaplastic carcinoma of the thyroid: a 24-year experience. Head Neck 1995;17:41–47.
   PubMed Web of Science ®Google Scholar
• Sugitani I, Kasai N, Fujimoto Y, Yanagisawa A. Prognostic factors and therapeutic strategy for anaplastic carcinoma of the thyroid. World J Surg 2001;25:617–622.
   PubMed Web of Science ®Google Scholar
• Ansell SM, Grant CS, Habermann TM. Primary thyroid lymphoma. Semin Oncol 1999;26:316–323.
   PubMed Web of Science ®Google Scholar
• Derringer GA, Thompson LD, Frommelt RA, Bijwaard KE, Hefess CS, Abbondanzo SL. Malignant lymphoma of the thyroid gland: a clinicopathologic study of 108 cases. Am J Surg Pathol 2000;24:623–639.
   PubMed Web of Science ®Google Scholar
• Belal AA, Allam A, Kandil A, Husseiny G, Khafaga Y, Rajhi A, Ahmed G, Gray A, Ajarim D, Schultz H. Primary thyroid lymphoma: a retrospective analysis of prognostic factors and treatment outcome for localized intermediate and high grade lymphoma. Am J Clin Oncol 2001;24:299–305.
   PubMed Web of Science ®Google Scholar
• Graff-Baker A, Sosa JA, Roman SA. Primary thyroid lymphoma: a review of recent developments in diagnosis and histology-driven treatment. Curr Opin Oncol 2010;22:17–22.
   Google Scholar
• Holm LE, Blomgren H, Lowhagen T. Cancer risks in patients with chronic lymphocytic thyroiditis. N Eng J Med 1985;312:601–604.
   PubMed Web of Science ®Google Scholar
• Hwang YC, Kim TY, Kim WB, Shong YK, Yi KH, Shong M, Jo YS, Kim WS, Chung JH. Clinical characteristics of primary thyroid lymphoma in Koreans. Endocr J 2009;56:399–405.
   PubMed Web of Science ®Google Scholar
• Graff-Baker A, Roman SA, Thomas DC, Udelsman R, Sosa JA. Prognosis of primary thyroid lymphoma: demographic, clinical and pathologic predictors of survival in 1,408 cases. Surgery 2009;146: 1105–1115.
   PubMed Web of Science ®Google Scholar
• Mazzaferri EL, Kloos RT. Current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab 2001;86:1447–1463.
   PubMed Web of Science ®Google Scholar
• Pacini F, Schlumberger M, Dralle H, Elisei R, Smit JW, Wiersinga W. European consensus for the management of patients with differentiated thyroid cancer of the follicular epithelium. Eur J Endocrinol 2006;154:783–803.
   Google Scholar
• Cooper D, Doherty G, Haugen B, et al. Revised thyroid association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009;19: 1167–1214.
   PubMed Web of Science ®Google Scholar
• Mazzaferri EL, Jhiang SM. Differentiated thyroid cancer long-term impact of initial therapy. Trans Am Clin Climatol Assoc 1994;106:151–168.
   Google Scholar
• Samaan NA, Shultz PN, Hickey RC, Goepfert H, Haynie TP, Johnston DA, Ordonez NG. The results of various modalities of treatment of well differentiated thyroid carcinomas: a retrospective review of 1599 patients. J Clin Endocrinol Metab 1992;75:714–720.
   PubMed Web of Science ®Google Scholar
• Sawka AM, Brierley JD, Tsang RW, et al. An updated systematic review and commentary examining the effectiveness of radioactive iodine remnant ablation in well-differentiated thyroid cancer. Endocrinol Metab Clin North Am 2008;37:457–480.
   PubMed Web of Science ®Google Scholar
• Cappola AR, Fried LP, Arnold AM, et al. Thyroid status, cardiovascular risk, and mortality in older adults. JAMA 2006;295:1033–1041.
   PubMed Web of Science ®Google Scholar
• Kloos RT, Eng C, Evans DB, et al. Medullary thyroid cancer: management guidelines of the American Thyroid Association. Thyroid 2009;19:565–612.
   PubMed Web of Science ®Google Scholar
• Brierley J, Tsang R, Simpson WJ, et al. Medullary thyroid cancer: analysis of survival and prognostic factors and the role of radiation therapy in local control. Thyroid 1996;6:305–310.
   PubMed Web of Science ®Google Scholar
• Neff RL, Farrar WB, Kloos RT. Anaplastic thyroid cancer. Endocrinol Metab Clin N Am 2008;37:525–538.
   PubMed Web of Science ®Google Scholar
• Pfreundschuh M, Schubert J, Ziepert M, et al. Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60). Lancet Oncol 2008;9:105–116.
   PubMed Web of Science ®Google Scholar